US Stock MarketDetailed Quotes

CLDX Celldex Therapeutics

Watchlist
  • 20.290
  • -0.370-1.79%
Close May 5 16:00 ET
  • 19.529
  • -0.761-3.75%
Post 20:01 ET
1.35BMarket Cap-8.28P/E (TTM)

About Celldex Therapeutics Company

Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. Its pipeline includes Varlilumab, CDX-1140, and CDX-301, and CDX-3379. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.

Company Profile

SymbolCLDX
Company NameCelldex Therapeutics
Listing DateMay 1, 1986
Founded1983
CEOMr. Anthony S. Marucci
MarketNASDAQ
Employees186
Fiscal Year Ends12-31
AddressPerryville III Building,53 Frontage Road,Suite 220
CityHampton
ProvinceNew Jersey
CountryUnited States of America
Zip Code08827
Phone1-908-454-7120

Company Executives

  • Name
  • Position
  • Salary
  • Anthony S. Marucci
  • Director, President and Chief Executive Officer
  • 9.23M
  • Elizabeth Crowley
  • Senior Vice President and Chief Product Development Officer
  • 2.93M
  • Sam Martin
  • Treasurer, Senior Vice President, Secretary, Principal Accounting Officer and Chief Financial Officer
  • 2.84M
  • Richard M. Wright, PhD
  • Senior Vice President and Chief Commercial Officer
  • --
  • Dr. Tibor Keler, PhD
  • Executive Vice President and Chief Scientific Officer
  • 3.29M
  • Dr. Ronald A. Pepin, PhD
  • Senior Vice President and Chief Business Officer
  • --
  • Dr. Diane C. Young, M.D.
  • Senior Vice President and Chief Medical Officer
  • --
  • Sarah Cavanaugh
  • Senior Vice President, Corporate Affairs and Administration
  • --
  • Freddy A. Jimenez
  • Senior Vice President and General Counsel
  • --
  • Dr. Margo Heath-Chiozzi, M.D.
  • Senior Vice President, Regulatory Affairs
  • 2.86M
  • Karen L. Shoos
  • Chairman of the Board
  • 515.55K
  • Herbert J. Conrad
  • Independent Director
  • 490.55K
  • Denice M. Torres, J.D.,M.B.A.
  • Independent Director
  • --
  • Cheryl L. Cohen
  • Independent Director
  • 493.05K
  • Keith L. Brownlie
  • Independent Director
  • 500.55K
  • Herbert J. Conrad
  • Independent Director
  • --
  • Harry H. Penner, Jr
  • Independent Director
  • 498.05K
  • Dr. Rita I. Jain, M.D.
  • Independent Director
  • 490.55K
  • Dr. James J. Marino, J.D.
  • Independent Director
  • 505.55K
  • Dr. Garry A. Neil, M.D.
  • Independent Director
  • 495.55K

Market Insights

Discussing

Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve Show More
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Unlock Now

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.